FIBRONEER ON BI-1305-0031
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
May 6, 2024
End Date
March 3, 2029
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
May 6, 2024
End Date
March 3, 2029